- Home
- SCLX vs HYMC Comparison
SCLX vs HYMC Comparison
Compare SCLX & HYMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- HYMC
- Stock Information
- Founded
- SCLX 2011
- HYMC N/A
- Country
- SCLX United States
- HYMC United States
- Employees
- SCLX N/A
- HYMC N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- HYMC Precious Metals
- Sector
- SCLX Health Care
- HYMC Basic Materials
- Exchange
- SCLX Nasdaq
- HYMC Nasdaq
- Market Cap
- SCLX 61.5M
- HYMC 50.2M
- IPO Year
- SCLX N/A
- HYMC N/A
- Fundamental
- Price
- SCLX $0.33
- HYMC $2.40
- Analyst Decision
- SCLX Strong Buy
- HYMC
- Analyst Count
- SCLX 4
- HYMC 0
- Target Price
- SCLX $14.00
- HYMC N/A
- AVG Volume (30 Days)
- SCLX 184.3K
- HYMC 234.5K
- Earning Date
- SCLX 03-11-2025
- HYMC 03-12-2025
- Dividend Yield
- SCLX N/A
- HYMC N/A
- EPS Growth
- SCLX N/A
- HYMC N/A
- EPS
- SCLX N/A
- HYMC N/A
- Revenue
- SCLX $55,152,000.00
- HYMC N/A
- Revenue This Year
- SCLX $24.19
- HYMC N/A
- Revenue Next Year
- SCLX $109.90
- HYMC N/A
- P/E Ratio
- SCLX N/A
- HYMC N/A
- Revenue Growth
- SCLX 22.02
- HYMC N/A
- 52 Week Low
- SCLX $0.32
- HYMC $1.87
- 52 Week High
- SCLX $2.63
- HYMC $4.65
- Technical
- Relative Strength Index (RSI)
- SCLX 30.09
- HYMC 45.94
- Support Level
- SCLX $0.33
- HYMC $2.65
- Resistance Level
- SCLX $0.36
- HYMC $3.05
- Average True Range (ATR)
- SCLX 0.03
- HYMC 0.20
- MACD
- SCLX -0.00
- HYMC -0.01
- Stochastic Oscillator
- SCLX 8.90
- HYMC 9.72
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About HYMC Hycroft Mining Holding Corporation
Hycroft Mining Holding Corp is a gold and silver producer. Its operating mine, the Hycroft Mine, is an open-pit heap leach operation located approximately fifty four miles west of Winnemucca, Nevada.